57 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissuei Celli Pathologyi Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
CD300CCD300c moleculeCD markers
Predicted membrane proteins
Testis cancer: 8.53e-5
Tissue enhanced
SNX31Sorting nexin 31Predicted intracellular proteins
Transporters
Nucleoplasm
Golgi apparatus
Cytosol
Testis cancer: 1.47e-4
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 2.09e-8
Testis cancer: 1.74e-4
Tissue enhanced
PIN4Peptidylprolyl cis/trans isomerase, NIMA-interacting 4Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli
Testis cancer: 2.58e-4
Urothelial cancer: 2.66e-4
Lung cancer: 6.37e-4
Expressed in all
CLCN7Chloride voltage-gated channel 7Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleoplasmTestis cancer: 3.21e-4
Head and neck cancer: 5.23e-4
Expressed in all
GUCY1B3Guanylate cyclase 1 soluble subunit betaEnzymes
Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.42e-4
Testis cancer: 3.23e-4
Expressed in all
IFT52Intraflagellar transport 52Disease related genes
Predicted intracellular proteins
CytosolLiver cancer: 3.30e-6
Testis cancer: 3.33e-4
Expressed in all
DVL1Dishevelled segment polarity protein 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Testis cancer: 3.33e-4
Expressed in all
GUCY1A3Guanylate cyclase 1 soluble subunit alphaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusLung cancer: 2.38e-4
Testis cancer: 3.59e-4
Renal cancer: 7.59e-4
Tissue enhanced
IQCCIQ motif containing CPredicted intracellular proteins
VesiclesPancreatic cancer: 8.23e-5
Testis cancer: 3.79e-4
Lung cancer: 5.65e-4
Tissue enhanced
CSF3RColony stimulating factor 3 receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Testis cancer: 3.79e-4
Renal cancer: 5.72e-4
Tissue enhanced
TLR4Toll like receptor 4CD markers
Predicted membrane proteins
Golgi apparatus
Cytosol
Testis cancer: 3.79e-4
Endometrial cancer: 6.29e-4
Mixed
WBSCR17Williams-Beuren syndrome chromosome region 17Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Nucleoli
Nuclear bodies
Golgi apparatus
Testis cancer: 3.91e-4
Ovarian cancer: 4.60e-4
Tissue enhanced
GGA2Golgi associated, gamma adaptin ear containing, ARF binding protein 2Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusCervical cancer: 1.71e-5
Renal cancer: 3.91e-5
Head and neck cancer: 9.70e-5
Lung cancer: 1.68e-4
Testis cancer: 4.15e-4
Expressed in all
BST2Bone marrow stromal cell antigen 2CD markers
Plasma proteins
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cytosol
Renal cancer: 3.56e-9
Testis cancer: 4.22e-4
Breast cancer: 6.69e-4
Expressed in all
CLEC10AC-type lectin domain family 10 member ACD markers
Predicted intracellular proteins
Predicted membrane proteins
Head and neck cancer: 1.26e-5
Testis cancer: 4.22e-4
Lung cancer: 9.24e-4
Mixed
SIGLEC1Sialic acid binding Ig like lectin 1CD markers
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 8.69e-5
Testis cancer: 4.36e-4
Mixed
HRASLSHRAS like suppressorPredicted membrane proteins
Focal adhesion sites
Cytosol
Testis cancer: 4.36e-4
Group enriched
FCHSD1FCH and double SH3 domains 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 6.19e-6
Urothelial cancer: 1.21e-4
Testis cancer: 4.77e-4
Breast cancer: 8.62e-4
Mixed
CCDC74ACoiled-coil domain containing 74APredicted intracellular proteins
VesiclesRenal cancer: 1.70e-7
Glioma: 1.82e-4
Testis cancer: 4.92e-4
Breast cancer: 5.11e-4
Tissue enhanced
CSF1RColony stimulating factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Vesicles
Plasma membrane
Renal cancer: 1.08e-4
Testis cancer: 4.92e-4
Mixed
FKBP15FK506 binding protein 15Predicted intracellular proteins
Nucleoli
Cytosol
Testis cancer: 4.92e-4
Expressed in all
HELZ2Helicase with zinc finger 2Plasma proteins
Predicted intracellular proteins
Testis cancer: 4.92e-4
Mixed
SGSHN-sulfoglucosamine sulfohydrolaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 2.66e-4
Lung cancer: 2.72e-4
Pancreatic cancer: 3.10e-4
Testis cancer: 5.37e-4
Liver cancer: 7.71e-4
Expressed in all
PRKRAProtein activator of interferon induced protein kinase EIF2AK2Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 8.33e-5
Testis cancer: 5.45e-4
Expressed in all
TRPV2Transient receptor potential cation channel subfamily V member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 1.19e-6
Testis cancer: 5.53e-4
Mixed
CSF2RAColony stimulating factor 2 receptor alpha subunitCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Cervical cancer: 2.38e-5
Head and neck cancer: 2.81e-4
Testis cancer: 5.53e-4
Tissue enhanced
LY86Lymphocyte antigen 86Predicted secreted proteins
Testis cancer: 5.61e-4
Tissue enhanced
TBC1D2TBC1 domain family member 2Predicted intracellular proteins
Nucleus
Cytosol
Head and neck cancer: 2.77e-4
Testis cancer: 5.62e-4
Mixed
C15orf39Chromosome 15 open reading frame 39Predicted intracellular proteins
CytosolRenal cancer: 3.05e-4
Testis cancer: 6.02e-4
Melanoma: 7.94e-4
Tissue enhanced
CITED1Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Thyroid cancer: 3.95e-4
Testis cancer: 6.10e-4
Tissue enriched
LAT2Linker for activation of T-cells family member 2Disease related genes
Predicted secreted proteins
Renal cancer: 4.10e-4
Testis cancer: 6.10e-4
Tissue enhanced
GIMAP1GTPase, IMAP family member 1Predicted membrane proteins
Endoplasmic reticulumLiver cancer: 1.09e-4
Testis cancer: 6.12e-4
Tissue enhanced
LITAFLipopolysaccharide induced TNF factorDisease related genes
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
Glioma: 1.78e-4
Testis cancer: 6.25e-4
Expressed in all
PAG1Phosphoprotein membrane anchor with glycosphingolipid microdomains 1Predicted intracellular proteins
Vesicles
Plasma membrane
Renal cancer: 1.24e-6
Testis cancer: 6.82e-4
Mixed
ITGAMIntegrin subunit alpha MCancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 6.93e-5
Liver cancer: 3.43e-4
Testis cancer: 6.93e-4
Tissue enhanced
ALG1ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli fibrillar center
Endoplasmic reticulum
Colorectal cancer: 5.79e-4
Testis cancer: 6.93e-4
Expressed in all
LRRC25Leucine rich repeat containing 25Predicted membrane proteins
Testis cancer: 6.93e-4
Tissue enhanced
VSIRV-set immunoregulatory receptorPredicted membrane proteins
NucleoplasmTestis cancer: 6.93e-4
Expressed in all
GGT5Gamma-glutamyltransferase 5Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Nucleoli fibrillar centerRenal cancer: 6.36e-5
Stomach cancer: 4.06e-4
Testis cancer: 6.97e-4
Mixed
ARHGEF4Rho guanine nucleotide exchange factor 4Plasma proteins
Predicted intracellular proteins
Testis cancer: 7.00e-4
Tissue enhanced
LST1Leukocyte specific transcript 1Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 5.97e-5
Testis cancer: 7.62e-4
Cervical cancer: 7.89e-4
Tissue enhanced
FAM105AFamily with sequence similarity 105 member AEnzymes
Predicted membrane proteins
Nucleoli
Cytosol
Pancreatic cancer: 1.02e-4
Testis cancer: 7.62e-4
Mixed
NEK6NIMA related kinase 6Enzymes
Predicted intracellular proteins
Transporters
Nucleoplasm
Microtubule organizing center
Cytosol
Testis cancer: 7.66e-4
Expressed in all
CCR7C-C motif chemokine receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched
TPGS2Tubulin polyglutamylase complex subunit 2Predicted intracellular proteins
NucleoliLiver cancer: 1.24e-5
Ovarian cancer: 1.93e-5
Cervical cancer: 4.09e-4
Testis cancer: 7.74e-4
Expressed in all
PRR36Proline rich 36Predicted intracellular proteins
Nucleus
Golgi apparatus
Testis cancer: 7.74e-4
Tissue enriched
C5AR1Complement C5a receptor 1CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 1.16e-4
Cervical cancer: 4.71e-4
Testis cancer: 7.99e-4
Ovarian cancer: 9.55e-4
Tissue enhanced
IL1RNInterleukin 1 receptor antagonistCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 2.66e-6
Endometrial cancer: 3.00e-4
Pancreatic cancer: 6.85e-4
Testis cancer: 8.23e-4
Tissue enhanced
PPP6R3Protein phosphatase 6 regulatory subunit 3Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Testis cancer: 8.23e-4
Expressed in all
Page of 2 | next »